Offer - Urjas Oil for just ₹ 1 X
Nevirin NT 75mg/10mg/1500mcg Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nevirin NT 75mg/10mg/1500mcg Tablet (10) safe for pregnant women?
Nevirin NT Tablet is safe to take during pregnancy.
Is the use of Nevirin NT 75mg/10mg/1500mcg Tablet (10) safe during breastfeeding?
Nevirin NT Tablet is completely safe for breastfeeding women.
What is the effect of Nevirin NT 75mg/10mg/1500mcg Tablet (10) on the Kidneys?
Nevirin NT Tablet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Nevirin NT 75mg/10mg/1500mcg Tablet (10) on the Liver?
Nevirin NT Tablet is rarely harmful for the liver.
What is the effect of Nevirin NT 75mg/10mg/1500mcg Tablet (10) on the Heart?
Nevirin NT Tablet may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Nevirin NT 75mg/10mg/1500mcg Tablet (10) unless your doctor advises you to do so -
Is this Nevirin NT 75mg/10mg/1500mcg Tablet (10) habit forming or addictive?
Nevirin NT 75mg/10mg/1500mcg Tablet (10) is not addictive in nature.
Interaction between Food and Nevirin NT 75mg/10mg/1500mcg Tablet (10)
Eating certain foods may increase the time it takes Nevirin NT 75mg/10mg/1500mcg Tablet (10) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nevirin NT 75mg/10mg/1500mcg Tablet (10)
Information about the interaction of Nevirin NT 75mg/10mg/1500mcg Tablet (10) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420